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1.1. Trypsin and chymotrypsin inhibitors
Trypsin inhibitors CMTI-I and CMTI-III (Cucurbita
maxima trypsin inhibitor) are the ﬁrst two members of a
family which represent the lowest molecular weight
peptidic serine proteinase inhibitors isolated to date.
Despite their small size, these potent trypsin inhibitors
have equilibrium constants (Ka) of 3.2 · 1011 and
6.8 · 1011 M1 for CMTI-I and CMTI-III respectively.
The peptides contain a reactive peptide bond (P1-P
0
1)
located between Arg5 and Ile6 residues. X-ray crystal-
lography has demonstrated that 13 amino acid residues
(fragments 1–7, Glu9 and fragments 25–29) of CMTI-I
are directly involved in its interaction with trypsin.
These inhibitors have potential therapeutic applicability,
and recently, the N-terminal segment of CMTI, which is
directly involved in the interaction with bovine b-tryp-
sin, has been investigated as a possible template to
design novel low molecular weight proteinase inhibi-
tors.1
A solid phase library of 2016 decapeptides in mixtures
was synthesised on TentaGel S Ac with attached Fmoc-
Gly resin. Decapeptides were screened against bovine
b-trypsin and bovine a-chymotrypsin. The deconvolu-
tion process identiﬁed active peptide constituents, one of
which was (i) which possessed a Ka of 1.1 · 108 M1
against bovine b-trypsin. Although this analogue is less
active than the wild CMTI inhibitors, it has lower
molecular weight and fewer conformational constraints.
Thus, this series represents a promising starting point
for further optimisation of these low molecular weight
structure serine proteinase inhibitors.E-mail: nick_terrett@cambridge.pﬁzer.com
doi:10.1016/j.comche.2004.03.001(i)
[Har1, Gly3, Har9, Gly10]CMTI-III1-10
1.2. Sodium channel agonists
Chronic pain represents a disease for which there is
currently a signiﬁcant unmet medical need. According to
statistics from the American Society of Anesthesiolo-
gists, back pain disables 5 million people per year in the
United States. Another 66 million people experience
pain related to arthritis, 40 million people have recurrent
severe headaches, and 90% of terminal cancer patients
suﬀer from severe pain. Prescribed non-steriodal anti-
inﬂammatory agents, over-the-counter pain medication
or, in the most severe cases, opioids, are the front line
therapies currently used to treat the condition. Many of
these treatments have undesirable side eﬀects and the
discovery of a broad spectrum, highly eﬀective analgesic
agent that is devoid of side eﬀects is a common goal
within the pharmaceutical industry.
Ion channels that regulate the excitability of sensory
neurons might represent plausible drug targets for the
treatment of chronic pain. Speciﬁcally, voltage-gated
sodium channels are attractive targets because they are
essential for the inhibition and propagation of neuronal
impulses. Additionally, they play a critical role in
determining the activation threshold and ﬁring patterns
in injured primary aﬀerent neurons. Thus, optimisation
of sodium channel antagonist pharmacology as an
approach to the discovery of new analgesic agents has
been a recent goal.2
A library of 91 thiazolidinone compounds based on a
known anticonvulsant/sodium channel blocker was
synthesised as singletons via a solution-phase multi-
component reaction. The compounds were tested for
10 N. K. Terrett / Combinatorial Chemistry - An Online Journal 6 (2004) 9–12sodium channel inhibition in Xenopus laevis oocytes.
One of the most potent compounds found was (ii) which
displayed a Ki of 90 nM. This work has produced potent
and novel sodium channel antagonists which may lead
to improved pharmaceutical and pharmacological
properties.
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2. A summary of the papers in this month’s issue
2.1. Solid-phase synthesis
Amino-acridine conjugates play an important role as
biochemical probes and/or drugs, and the solid-phase
synthesis of such compounds suitable for library con-
struction and biological screening has been reported.3
The solid-phase synthesis of 1,5-substituted 2-(N-
alkylamino)-imidazolidin-4-one from resin-bound ami-
no acids has been described.4
The solid-phase synthesis of a series of imidazo[1,2-
b]pyrazol-2-ones, an interesting 5,5-fused ring system,
based on diverse set of hydrazine acids and malono-
nitriles has been published. The method involves for-
mation of 5-aminopyrazoles on solid support and
subsequent cyclisative cleavage oﬀ the resin.5
Resin-bound a-keto mesylates were cleaved under acidic
conditions (TFA/CH2Cl2) in the presence of a variety of
aryl or alkyl thiols to give the corresponding thioethers.6
A solid-phase version of the Nozaki-Hiyama allylation
of supported allylic bromides with aldehydes has been
described.7
The design and synthesis of a new water-soluble
N-protecting group, 2-[phenyl(methyl)sulfonio]ethoxy-
carbonyl (Pms), and the study of its introduction onto
amino acids so as to permit solid-phase peptide synthesis
in water has been described. The solid-phase synthesis of
Leu- and Met-enkephalin amides using Pms-protected
amino acids was successfully achieved in water.82.2. Solution-phase synthesis
Single mode microwave-assisted combinatorial synthesis
of biologically interesting chiral quinoxalinones on sol-
uble polymer support utilizing SNAr reactions and
reduction, followed with concomitant cyclisation has
been described.9A general and rapid synthesis of new families of pyr-
rolizines and indolizines in good overall yields via an
intramolecular [3 + 2] cycloaddition reaction has been
recently described.102.3. Novel resins and linkers
The use of chiral auxiliaries in polymer-supported
organic synthesis has been reviewed. In many of the
examples presented, not only does the auxiliary serve as
an element for inducing asymmetry into the synthesis,
but it also functions as the linker for attaching the
synthesis substrate to the polymer support.112.4. Library intermediates
An eight-step synthesis of an orthogonally protected
3,8-diazabicyclo[3.2.1]octane from commercially avail-
able pyroglutamic acid has been developed. The target
compound can be used as a versatile building block for
combinatorial synthesis of pharmacologically useful
compounds.12
A key step for the synthesis of a versatile diazepanone
scaﬀold dedicated to a library of liposidomycin ana-
logues has been described.132.5. Library applications
Combinatorial development of new catalysts with
phosphodiesterase and esterase activities requires spe-
ciﬁc ﬂuorescent probes that have been synthesized with
special attention to solubility in water. The probes
reported include a compound based on a ﬂuorescein
ﬂuorophore, a compound for FRET-detection of
phosphodiester hydrolysis and a compound based on a
quinolinium ﬂuorophore.14
Polyamine pathways have been reported as potential
targets for the development of new chemotherapies
against parasitic diseases. In the recent study, diﬀerent
libraries of substituted diamines totalling 78 compounds
were synthesized on solid support and their activi-
ties against malaria and leishmania parasites determined.15
The synthesis of a series of low molecular weight
inhibitors of the avb3 integrin obtained by modifying a
high-throughput screening hit with micromolar activity
has been reported. Compounds with nanomolar activity
in the biochemical assay and able to eﬃciently inhibit
cell adhesion mediated by vitronectin were obtained.16
The discovery of a series of potent, selective and
reversible caspase-3 inhibitors employing combinatorial
chemistry, structural biology and molecular modelling
has been reported.17
The SAR from peptide libraries was exploited to design
a series of potent deoxybenzoin PTP-1B inhibitors.
These compounds were orally bioavailable and active in
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mellitus (NIDDM).18
Following the discovery of a submicromolar CCK1
receptor antagonist, a recent report describes the prep-
aration and test of a library of non-peptide CCK1
antagonist analogues based on this lead.19
To identify novel proteins regulating the microtubule
cytoskeleton, a combinatorial library of 2,6,9-trisubsti-
tuted purine derivatives was screened using mitotic
spindle assembly in Xenopus egg extracts as an assay.
Out of a collection of 1561 compounds, 15 were iden-
tiﬁed that destabilized microtubules without targeting
tubulin directly, resulting in small spindles.20References
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